-
Cost-Effectiveness Analysis of Aztreonam Avibactam (ATMAVI) ± Metronidazole (MTZ) for the Treatment of Complicated Intra-Abdominal Infections (cIAIs) and Ventilator-Associated Hospital-Acquired Pneumonia (HAP/VAP) Caused by Suspected MBL-Producing...
Sep 9, 2025, 16:22 PM -
A Gap Analysis of HTA Methods in Europe: Results From SUSTAIN-HTA
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of the 13-Valent Pneumococcal Conjugate Vaccine Compared With Higher-Valent Alternatives in the Pediatric Population of Paraguay
Sep 9, 2025, 16:22 PM -
Exploring the Integration of Artificial Intelligence in Health Economic, Systematic Review, and Evidence Synthesis Methods: A Scoping Review of NICE Technology Appraisal and Assessment Reports
Sep 9, 2025, 16:22 PM -
Comparison of the Early Access and Postmarket Evaluation Systems in South Korea and Germany’s DIGA
Sep 9, 2025, 16:22 PM -
Innovative Approaches to Real-World Evidence Generation: The Role of Italian Community Pharmacies
Sep 9, 2025, 16:22 PM -
The Relationship Between Surrogate Endpoints and Overall Survival in Myelofibrosis Clinical Trials: Results From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Trends in Vaccination at Pharmacies by Race Among Medicaid Recipients: A Claims Analysis
Sep 9, 2025, 16:22 PM -
Modeling the Healthcare Burden of Oral Corticosteroid Use in Mexico
Sep 9, 2025, 16:22 PM -
From Admission to Discharge: Understanding the Transplant Patient Journey With German Statutory Health Insurance Claims Data
Sep 9, 2025, 16:22 PM -
How Can the Threshold Method Guide the Choice of Treatments? Illustration in French Patients With Hemophilia A or B
Sep 9, 2025, 16:22 PM -
Cross-Agency Analysis of Six-Minute Walk Test (6MWT) Adoption in Muscular and Nonmuscular Neurological HTA Submissions: Assessing Surrogate Endpoints for Disease Progression
Sep 9, 2025, 16:22 PM -
Relevance of Quality Indicators for Supporting Patients’ Choice of Hospitals: An Online Survey
Sep 9, 2025, 16:22 PM -
A Conceptual Paper on Integrating a Pharmacometric Multistate Model With Cost-Effectiveness Analysis for Infectious Diseases Treatment Optimization
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Control-IQ Hybrid Closed-Loop System in Adults With Type 1 Diabetes in Sweden
Sep 9, 2025, 16:22 PM -
Using Social Media Listening to Understand Oncology-Specific Patient Experiences: A Comparison of Pharmaceutical Industry-Funded vs. Nonpharmaceutical Industry-Funded Studies
Sep 9, 2025, 16:22 PM -
Navigating Joint Clinical Assessment in Europe: Strategic Roadmap and Recommendations for Health Technology Developers
Sep 9, 2025, 16:22 PM -
Validation Between Antidepressant Treatment Failure Proxy and PHQ-9 Score in Major Depressive Disorder Using a Linked Insurance Claims and Electronic Health Record Dataset
Sep 9, 2025, 16:22 PM -
Does Insurance Value in Metastatic Breast Cancer Vary by Age Testing for Variation in Willingness to Pay for Novel Treatments Among Women in the US?
Sep 9, 2025, 16:22 PM -
Clinical Outcome Assessments in Drug Approvals: Trends and Insights From FDA; EMA Labeling 2018-2023
Sep 9, 2025, 16:22 PM
